Last Updated:
NameDesignationAppointment DateStatus
Arjun Mashribhai Gojiya

Appointed as Managing Director since April 2023

Managing Director10-Apr-2023Current
Rohit Lashkari

Appointed as Director since April 2023

Director10-Apr-2023Current
Yash Der

Appointed as Director since April 2023

Director10-Apr-2023Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Emvet Pharmaceutical Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Emvet Pharmaceutical Private Limited's leadership journey.

Loading...
Contact Details
  • Address Office No. 219, Second Floor,, Madhavdarshan Complex, Sheet No. 284, C.S. No. 1104, Opp. Cricket Bunglow,, Kalavad Gujarat, 361001, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 361001
  • Country India
  • Website -
Frequently Asked Questions
You can contact Emvet Pharmaceutical Private Limited through their registered address at Office No. 219, Second Floor,, Madhavdarshan Complex, Sheet No. 284, C.S. No. 1104, Opp. Cricket Bunglow,, Kalavad Gujarat, 361001, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Emvet Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • YASH DER
  • ROHIT LASHKARI
  • ARJUN MASHRIBHAI GOJIYA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available